Valvular & structural heart disease

Left Ventricular Health and Transcatheter Aortic Valve Replacement (TAVR) Timing in Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

J Am Coll CardiolPublished Secondary analysis of the EARLY TAVR randomised trial

Authors' conclusion

For patients with asymptomatic severe AS, the benefit of early TAVR, compared with CS, is consistent regardless of baseline LV health according to integrated or individual measures.

Study context

Population
Patients with asymptomatic severe aortic stenosis (AS)
Participants
901 patients
Comparison
Early TAVR vs clinical surveillance, by baseline left ventricular (LV) health
  • TAVRn = 455
  • Clinical surveillance (CS)n = 446reference
Methodological detailsmulticentre, 75 centres in US and Canada, core laboratory echocardiography, exploratory effect-modification analyses
  • Multicentre
  • 75 centres in US and Canada
  • Core laboratory echocardiography
  • Exploratory effect-modification analyses

Primary result

As reported in the abstract

Benefit of early TAVR vs CS by baseline LV health
  • Benefit of early TAVR vs CS consistently observed regardless of whether LV health (integrated and individual components) was normal or not
  • Exploratory (LV health not prespecified as stratification variable)

Secondary outcomes

Normal integrated LV health (ITT) · 2 years · intention-to-treat · prespecified secondary endpoint · also less frequent for component measures with CS

P < 0.001

Normal integrated LV health at baseline (ITT) · randomization

Normal integrated LV health
27%
Normal LV mass index (LVMi)
64%
Normal left atrial volume index (LAVi)
42%
Normal global longitudinal strain (GLS)
88%
Abnormal integrated LV health and each component generally associated with higher event rates across several composite endpoints

LV health in CS patients undergoing delayed AVR · randomization to preprocedure

LV health tended to decline (all measures except GLS)
P < 0.10
Baseline LV health did not predict timing of conversion to AVR nor severity of presentation

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Left Ventricular Health and TAVR Timing in Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial. J Am Coll Cardiol. Published 7 September 2025. doi:10.1016/j.jacc.2025.08.071

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.